WallStSmart
SXTC

China SXT Pharmaceuticals Inc

NASDAQ: SXTC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$2.06
+0.49% today

Updated 2026-04-30

Market cap
$2.00M
P/E ratio
P/S ratio
1.30x
EPS (TTM)
$-57.15
Dividend yield
52W range
$1 – $368
Volume
0.1M

WallStSmart proprietary scores

38
out of 100
Grade: D
Sell
Investment rating
4.7
Growth
C
5.0
Quality
C+
2.5
Profitability
F
5.3
Valuation
C+
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$—
12-Month target
Intrinsic (DCF)
$2.61
Margin of safety
+4.60%

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-495089.00
- Revenue declining -24.50% QoQ

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$2.60M$1.97M$1.93M$1.74M$1.54M
Net income$-5.74M$-5.93M$-3.10M$-3.30M$-1.25M
EPS$-57.15
Free cash flow$205803.00$-151441.00$-1.94M$-2.35M$-495089.00
Profit margin-220.43%-301.00%-160.67%-189.77%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
SXTC$2.00M384.72.55.35.0+4.60%Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

China SXT Pharmaceuticals Inc trades at $2.06. Our Smart Value Score of 38/100 indicates the stock is weak. TTM revenue stands at $1.54M. Our DCF model estimates intrinsic value at $2.61.

Frequently asked questions

What is China SXT Pharmaceuticals Inc's stock price?
China SXT Pharmaceuticals Inc (SXTC) trades at $2.06.
Is China SXT Pharmaceuticals Inc overvalued?
Smart Value Score 38/100 (Grade D, Sell). DCF value $2.61.
What is the price target of China SXT Pharmaceuticals Inc (SXTC)?
The analyst target price is $—, representing NaN% downside from the current price of $2.06.
What is the intrinsic value of China SXT Pharmaceuticals Inc (SXTC)?
Based on our DCF model, intrinsic value is $2.61, a +4.6% margin of safety versus $2.06.
What is China SXT Pharmaceuticals Inc's revenue?
TTM revenue is $1.54M.

Company info

SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryChina
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio1.30x
ROE-50.30%
Beta1.75
50D MA$1.98
200D MA$145.68
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.1M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years